Companies: 10,795·Total market cap: $144.5T
Hyperfine, Inc.

Hyperfine, Inc.

HYPRNASDAQHealthcare● Active
$1.44
+$0.03(+2.12%)
Market Cap$121261248
P/E Ratio
52W High$2.22
52W Low$0.66

Hyperfine, Inc. (HYPR) Stock Ownership

Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.

SEC 13F · FMP · HYPR · as of Sep 30, 2025

Ownership Breakdown

Institutions 13.05%
Insiders 20.97%
Public 65.98%

47

Institutional Holders

▲ 7 vs Q2

$15.93M

Total Inst. Value

▲ $8.16M vs Q2

84.22M

Shares Outstanding

freeFloat 79.03%

10.99M

13F Shares Held

▲ 193,320 vs Q2

Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.

Top Institutional Holders

HYPR largest shareholders · institutional ownership

Q3 2025 · SEC 13F

Showing top 10 holders

HolderShares% OwnedWeightValueReportedChange

VANGUARD GROUP INC

electromedical & electrotherapeutic apparatus

3.51M4.50%

4.50%

$5.09BNov 7, 2025 190.1K

FOSUN INTERNATIONAL LTD

electromedical & electrotherapeutic apparatus

1.74M2.23%

2.23%

$2.53BNov 14, 2025— held

NORTHERN TRUST CORP

electromedical & electrotherapeutic apparatus

1.12M1.43%

1.43%

$1.62BNov 14, 2025— held

ALPHABET INC.

electromedical & electrotherapeutic apparatus

898.7K1.15%

1.15%

$1.30BNov 7, 2025— held

CATALIO CAPITAL MANAGEMENT, LP

electromedical & electrotherapeutic apparatus

684.5K87.67%

87.67%

$992.58MNov 14, 2025 75.5K

GEODE CAPITAL MANAGEMENT, LLC

electromedical & electrotherapeutic apparatus

672.0K86.07%

86.07%

$974.85MNov 12, 2025 1.6K

BLACKROCK, INC.

electromedical & electrotherapeutic apparatus

575.7K73.73%

73.73%

$834.73MNov 12, 2025— held

ISTHMUS PARTNERS, LLC

electromedical & electrotherapeutic apparatus

313.4K40.13%

40.13%

$454.36MNov 10, 2025— held

STATE STREET CORP

electromedical & electrotherapeutic apparatus

250.0K32.02%

32.02%

$362.49MNov 14, 2025 54.0K

JOURNEY STRATEGIC WEALTH LLC

electromedical & electrotherapeutic apparatus

186.7K23.92%

23.92%

$270.77MNov 12, 2025— held

Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).

Institutional Activity

Q3 2025 vs prior quarter

Q3 2025

Net institutional sentimentBullish — more buying than selling

10

Increased

+299.7K shares

10

New Positions

first time holders

7

Decreased

−294.1K shares

3

Sold Out

fully exited

Net shares change (top 50)

+5.6K

+299.7K / −294.1K

Net new holders

+10

10 new / 3 exited

Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).

Insider Buying vs Selling

HYPR insider trading · insider activity

Source: SEC Form 4

Buy 0%Active transactions only100% Sell

Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.

5

Buy transactions

2

Sell transactions

2.50

Buy/Sell ratio

$0M

Total disposed

Recent Insider Transactions

Showing 10 most recent · Common Stock only

Name · RoleDateTypeSharesPriceValueAfter Trans.Filing

Wolterman Dan

director

Jun 3, 2026Award52,600$1.49$78.4K52.6KForm 4 ↗

HALE BRETT

CFO and CAO

May 26, 2026Sale6,047$1.65$10.0K599.8KForm 4 ↗

TEISSEYRE THOMAS

Chief Operating Officer

May 26, 2026Sale6,047$1.65$10.0K678.6KForm 4 ↗

Fattori Ruth A

director

May 22, 2026Award157,700$1.49$235.0K157.7KForm 4 ↗

Wolterman Dan

director

May 22, 2026Award157,700$1.49$235.0K157.7KForm 4 ↗

Dahldorf John T

director

May 22, 2026Award157,700$1.49$235.0K157.7KForm 4 ↗

ROTHBERG JONATHAN M

May 22, 2026Award157,700$1.49$235.0K157.7KForm 4 ↗

HALE BRETT

CFO and CAO

Mar 31, 2026Award330,000605.8KForm 4 ↗

TEISSEYRE THOMAS

Chief Operating Officer

Mar 31, 2026Award330,000684.6KForm 4 ↗

Sainz Maria

President and CEO

Mar 31, 2026Award750,000789.6KForm 4 ↗

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

Hyperfine, Inc. (HYPR) is primarily owned by institutional investors, who hold approximately 13.1% of total shares outstanding. Company insiders own approximately 20.97%, while retail and public investors account for the remaining 65.98%.

The largest institutional shareholder of Hyperfine, Inc. is VANGUARD GROUP INC, holding approximately 3.51 million shares — equal to 4.50% of outstanding shares — as of September 30, 2025.

A total of 47 institutional investors currently hold HYPR stock, with a combined institutional value of approximately $15,931,966 as of the most recent 13F filing period.

Frequently asked questions

HYPR ownership

Hyperfine, Inc. (HYPR) is primarily owned by institutional investors, who hold approximately 13.1% of shares. The largest shareholder is VANGUARD GROUP INC with a 4.50% stake. Company insiders hold 20.97%. Data sourced from SEC Form 13F as of September 30, 2025.

who owns HYPR stockHYPR ownership structureSEC Form 13F institutional holdingsHYPR float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of September 30, 2025